(Allergan plc)

	AGN latest price $222.4413 (-1.12%) ($221.3410 - $224.3137) on Fri. Oct. 21, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.49% (three month average)
RSI	48
Latest Price	$222.4413(-1.12%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.3% a day on average for past five trading days.
Weekly Trend	AGN declines -1.6% a week on average for past two weeks.
Market Behavior	Rotation from value to growth for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(52%)    XLV(50%)    XBI(46%)    ARKG(43%)    SPY(42%)
Factors Impacting AGN price	AGN will decline at least -0.745% in a week (0% probabilities).   VIXM(-28%)    TLT(-16%)    UUP(-12%)    IPO(-6%)    SHY(-3%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.745% (StdDev 1.49%)
Hourly BBV	0 ()
Intraday Trend	-0.3%

1 - 5 Day Possible Target	$218.52(-1.76%)
Resistance Level	$225.35
5 Day Moving Average	$220.9(0.7%)
10 Day Moving Average	$223.3(-0.38%)
20 Day Moving Average	$225.35(-1.29%)
To recent high	-11.4%
To recent low	2.9%
Market Cap	$73.339b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed